What Is the Tasman Trial?

• References

• 1 Graafsma YF, Prins MH, Lensing AWA, de Haan RJ, Huisman MV, Büller HR. Bleeding classification in clinical trials: observer variability and clinical relevance. Thromb Haemost 1998; 78: 1189-92.
• 2 Koopman MMW, Prandoni P, Piovella F. et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-7.
• 3 International Committee of Medical Journal Editors.. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1991; 324: 424-8.
• 4 Cheng TO. Acronym aggravation. Br Heart J 1994; 71: 107-9.
• 5 Cheng TO. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice. Cardiology 1996; 87: 267.
• 6 Cheng TO. Acronymophilia: the exponential growth of the use of acronyms should be resisted. Br Med J 1994; 309: 683-4.